NEW LOGO(large_trans_solo).png

  • HOME

  • ABOUT

    • LEADERSHIP
    • ADVISORS

  • OUR PROGRAM

    • NASH
    • ASK1
    • ASK1 inhibitors in NASH
    • SRT-015

  • PUBLICATIONS

  • NEWS

    • Oct 18, 2021
    • Jun 23, 2021
    • Nov 16, 2020
    • Nov 2, 2020
    • Nov 9, 2018

  • CONTACT

  • More

    Use tab to navigate through the menu items.
    >

    Reduction of Hepatocyte Injury by SRT-015, a Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1 (ASK1)

    Poster presentation at AASLD The Liver Meeting 2020

    SRT AASLD 2020 Poster 1692 Final.pdf
    Back

    • HOME

    • ABOUT

      • LEADERSHIP
      • ADVISORS

    • OUR PROGRAM

      • NASH
      • ASK1
      • ASK1 inhibitors in NASH
      • SRT-015

    • PUBLICATIONS

    • NEWS

      • Oct 18, 2021
      • Jun 23, 2021
      • Nov 16, 2020
      • Nov 2, 2020
      • Nov 9, 2018

    • CONTACT

    • More

      Use tab to navigate through the menu items.

      Seal Rock Therapeutics - 500 Yale Ave N, Seattle, WA 98109, USA - info@sealrocktx.com - 206.401.5086